ES2169746T3 - Nueva forma galenica para la administracion transdermica. - Google Patents

Nueva forma galenica para la administracion transdermica.

Info

Publication number
ES2169746T3
ES2169746T3 ES95400949T ES95400949T ES2169746T3 ES 2169746 T3 ES2169746 T3 ES 2169746T3 ES 95400949 T ES95400949 T ES 95400949T ES 95400949 T ES95400949 T ES 95400949T ES 2169746 T3 ES2169746 T3 ES 2169746T3
Authority
ES
Spain
Prior art keywords
transdermal administration
galenic form
new galenic
active agent
compsn
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95400949T
Other languages
English (en)
Inventor
Philippe Laurent
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cephalon France SAS
Original Assignee
Laboratoire L Lafon SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoire L Lafon SA filed Critical Laboratoire L Lafon SA
Application granted granted Critical
Publication of ES2169746T3 publication Critical patent/ES2169746T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Dermatology (AREA)
  • Materials Engineering (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

LA INVENCION SE REFIERE A UNA COMPOSICION DESTINADA A FORMAR SOBRE LA PIEL UNA PELICULA PARA LA ADMINISTRACION TRANSDERMICA DE UN PRINCIPIO ACTIVO, QUE COMPRENDE: A) UN PRINCIPIO ACTIVO LIPOFILICO, B) DE 5 A 60% EN PESO DE UNA COMPOSICION POLIMERA A BASE DE SILICONA, C) DE 0 A 25% EN PESO DE UN PROMOTOR DE ABSORCION Y D) DE 25 A 95 EN PESO DE UN SOLVENTE VOLATIL.
ES95400949T 1994-04-29 1995-04-26 Nueva forma galenica para la administracion transdermica. Expired - Lifetime ES2169746T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9405272A FR2719220A1 (fr) 1994-04-29 1994-04-29 Nouvelle forme galénique pour l'administration transdermique.

Publications (1)

Publication Number Publication Date
ES2169746T3 true ES2169746T3 (es) 2002-07-16

Family

ID=9462709

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95400949T Expired - Lifetime ES2169746T3 (es) 1994-04-29 1995-04-26 Nueva forma galenica para la administracion transdermica.

Country Status (16)

Country Link
EP (1) EP0679392B1 (es)
JP (1) JP2740465B2 (es)
KR (1) KR100233770B1 (es)
AT (1) ATE210430T1 (es)
AU (1) AU680731B2 (es)
CA (1) CA2148112C (es)
DE (1) DE69524470T2 (es)
DK (1) DK0679392T3 (es)
ES (1) ES2169746T3 (es)
FR (1) FR2719220A1 (es)
HK (1) HK1008658A1 (es)
HU (1) HU221599B (es)
NZ (1) NZ272014A (es)
PT (1) PT679392E (es)
TW (1) TW448050B (es)
ZA (1) ZA953392B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2740038B1 (fr) * 1995-10-20 1998-01-02 Lafon Labor Composition pour l'administration transdermique
CN1256624A (zh) * 1996-10-24 2000-06-14 普罗克特和甘保尔公司 用于去除皮肤异味的组合物
US5968919A (en) * 1997-10-16 1999-10-19 Macrochem Corporation Hormone replacement therapy drug formulations for topical application to the skin
DE19830732B4 (de) * 1998-07-09 2008-11-13 Lts Lohmann Therapie-Systeme Ag Zusammensetzung, enthaltend mindestens einen die Blutfettwerte beeinflussenden Wirkstoff und seine Verwendung
US6512072B1 (en) 2000-06-12 2003-01-28 Dow Corning Corporation Fast cure film forming formulation
FR2827764B1 (fr) * 2001-07-27 2005-08-19 Oreal Composition, notamment cosmetique, renfermant un steroide et un glycol
JP2007511578A (ja) * 2003-11-21 2007-05-10 ガルデルマ・リサーチ・アンド・デヴェロップメント・エス・エヌ・セ ビタミンｄの投与のためのスプレー可能な組成物
FR2867682B1 (fr) * 2004-03-22 2009-06-05 Galderma Res & Dev Composition pharmaceutique anhydre associant un agent silicone et un principe actif solubilise.
FR2871695B1 (fr) * 2004-06-17 2008-07-04 Galderma Sa Composition pharmaceutique comprenant un agent silicone et deux principes actifs solubilises
JP2008502647A (ja) * 2004-06-17 2008-01-31 ガルデルマ・ソシエテ・アノニム シリコーン剤、コルチコステロイドおよびビタミンｄまたはその誘導体を含む乾癬治療用組成物
FR2887150B1 (fr) * 2005-06-17 2007-08-03 Galderma Res & Dev Composition pharmaceutique comprenant un elastomere organopolysiloxane et un principe actif solubilise
FR2909284B1 (fr) * 2006-11-30 2012-09-21 Galderma Sa Nouvelles compositions sous forme d'onguent sans vaseline comprenant un derive de vitamine d et eventuellement un anti-inflammatoire steroidien
US10265265B2 (en) 2007-03-15 2019-04-23 Drug Delivery Solutions Limited Topical composition
EP2008651A1 (en) 2007-06-26 2008-12-31 Drug Delivery Solutions Limited A bioerodible patch
HUE045467T2 (hu) 2011-03-14 2020-01-28 Drug Delivery Solutions Ltd Szemészeti készítmény
US20130323332A1 (en) * 2012-05-31 2013-12-05 Sherry May Raymond-Coblantz Hand and body moisturizing serum
EP3542788A1 (en) 2018-03-19 2019-09-25 MC2 Therapeutics Limited Topical composition comprising calcipotriol and betamethasone dipropionate

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3836647A (en) * 1970-10-22 1974-09-17 Dow Corning Wash-resistant skin preparation
DE2140491A1 (de) * 1971-08-12 1973-02-22 Pawlowa Komposition zur bakteriziden bearbeitung einzelner bereiche der menschlichen haut und zur behandlung von hauterkrankungen
US4584192A (en) * 1984-06-04 1986-04-22 Minnesota Mining & Manufacturing Company Film-forming composition containing an antimicrobial agent and methods of use
EP0289900A1 (en) * 1987-04-30 1988-11-09 Abbott Laboratories Topical antibacterial compositions
JPH02145512A (ja) * 1988-11-26 1990-06-05 Shin Etsu Chem Co Ltd 被膜形成型外用剤
IN172390B (es) * 1989-07-18 1993-07-10 Ethicon Inc
EP0409383B1 (en) * 1989-07-21 1994-04-06 Izhak Blank Estradiol compositions and methods for topical applications
TW247878B (es) * 1991-07-02 1995-05-21 Takeda Pharm Industry Co Ltd
GB9114346D0 (en) * 1991-07-03 1991-08-21 Dow Corning Sa A method of accelerating drug permeation
EP0560014A1 (en) * 1992-03-12 1993-09-15 Atrix Laboratories, Inc. Biodegradable film dressing and method for its formation

Also Published As

Publication number Publication date
DE69524470T2 (de) 2002-05-23
PT679392E (pt) 2002-05-31
EP0679392B1 (fr) 2001-12-12
AU1767595A (en) 1995-11-16
CA2148112A1 (en) 1995-10-30
HU9501245D0 (en) 1995-06-28
KR100233770B1 (ko) 1999-12-01
HK1008658A1 (en) 1999-05-14
JPH0859456A (ja) 1996-03-05
EP0679392A1 (fr) 1995-11-02
AU680731B2 (en) 1997-08-07
HU221599B (hu) 2002-11-28
KR950028767A (ko) 1995-11-22
JP2740465B2 (ja) 1998-04-15
FR2719220A1 (fr) 1995-11-03
NZ272014A (en) 1997-05-26
ATE210430T1 (de) 2001-12-15
ZA953392B (en) 1996-10-28
DE69524470D1 (de) 2002-01-24
TW448050B (en) 2001-08-01
DK0679392T3 (da) 2002-04-08
CA2148112C (en) 2001-01-30
FR2719220B1 (es) 1997-02-14
HUT75251A (en) 1997-05-28

Similar Documents

Publication Publication Date Title
ES2169746T3 (es) Nueva forma galenica para la administracion transdermica.
PT86426A (pt) Dispositivo resiliente para a administracao de um medicamento por via transdermica, e dispositivos empregando esteres/eteres de acidos gordos de alcanodiois como estimuladores da absorcao percutanea
NO843594L (no) Middel for transdermal administrering av legemiddelvirkestoffer
PT92131A (pt) Processo para a preparacao de meios para aplicacao transdermicacontendo gestodeno
DE69214938D1 (de) Mittel zur topischen verabreichung von arzneiwirkstoffen
DK0674913T3 (da) Ikke-okklusivt klæbende plaster til påföring af medicament i huden
DK0737066T3 (da) Transdermal indretning, der indeholder polyvinylpyrrolidon som opløselighedsforstærker
ES2110375T3 (es) Nimesulida para uso externo.
FI905892A (fi) Foerfarande foer framstaellning av ett transdermalt terapeutiskt system, vilket innehaoller buprenorfin som aktiv komponent.
DE69126270D1 (de) Transdermale therapeutische Zubereitungen
DE59309714D1 (de) Pharmazeutische und/oder kosmetische Zubereitung
DE69126649D1 (de) Medikament und sein Träger
DE69706070D1 (de) Zubereitung zur perkutanen verabreichung enthaltend 6-amino-5-chloro-1-isopropyl-2-(4-methyl-1-piperazinyl)benzimidazol
DE59003020D1 (de) Piroxicam enthaltende pharmazeutische Zusammensetzung zur topischen Anwendung.
ATE83668T1 (de) Pflaster zur transdermalen anwendung.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 679392

Country of ref document: ES